Endocrinology, Vol 135, 2058-2063, Copyright © 1994 by Endocrine Society

ARTICLES

Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type

SF Schlosser, OF Almeida, VK Patchev, A Yassouridis and J Elands
Department of Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany.

Previous work showed the existence of receptors for arginine vasopressin (AVP) in the anterior pituitary; these receptors were classified as belonging to a distinct AVP receptor subtype, referred to as AVP-V1b receptors, and are thought to mediate the well documented ACTH-releasing activity of AVP. In the present work, high affinity receptors for another neurohypophyseal hormone, oxytocin (OT), were also shown to be present within the rat anterior pituitary; to this end, [125I]d(CH2)5[Tyr(Me)2Thr4Tyr-NH2(9)]OVT was used as a ligand in receptor binding studies. Experiments on dispersed rat anterior pituitary cells in a superfusion system confirmed earlier reports that OT acts as an additional secretagogue of ACTH, with significant effects first seen at concentrations as low as 1 nM. Further studies addressed the question of whether stimulation of ACTH release is mediated by OT receptors or whether receptors for AVP (V1b receptors) might serve this role. For this, highly selective agonist and antagonist ligands of the OT receptor and nonselective agonist and antagonist ligands of the V1b receptor were employed. Neither the OT receptor agonist Thr4Gly7OT nor the OT receptor antagonist des-Gly(NH2)9d(CH2)5-[Tyr(Me)2 Thr4]OVT displayed any influence on basal ACTH release, and des-Gly(NH2)9d(CH2)5- [Tyr(Me)2Thr4]OVT did not interfere with OT-induced ACTH release; these results indicated that OT promotes ACTH release through a receptor(s) other than the OT receptor itself. Evidence for the involvement of AVP V1b receptors was provided by the observation that the AVP receptor antagonist dP[Tyr(Me2)]AVP completely abolished OT-elicited increases in ACTH release. Thus, AVP V1b receptors mediate the actions of two structurally related peptides on ACTH secretion; the role of OT receptors in adenohypophyseal function remains to be determined.

This article has been cited by other articles:

				K. Nakamura, Y. Fujiwara, R. Mizutani, A. Sanbe, N. Miyauchi, M. Hiroyama, J. Yamauchi, T. Yamashita, S. Nakamura, T. Mori, et al. Effects of Vasopressin V1b Receptor Deficiency on Adrenocorticotropin Release from Anterior Pituitary Cells in Response to Oxytocin Stimulation Endocrinology, October 1, 2008; 149(10): 4883 - 4891. [Abstract] [Full Text] [PDF]

				A. Domokos, Z. Mergl, I. Barna, G. B Makara, and D. Zelena Congenital vasopressin deficiency and acute and chronic opiate effects on hypothalamo-pituitary adrenal axis activity in Brattleboro rats J. Endocrinol., January 1, 2008; 196(1): 113 - 121. [Abstract] [Full Text] [PDF]

				Y. Fujiwara, M. Hiroyama, A. Sanbe, J. Yamauchi, G. Tsujimoto, and A. Tanoue Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice J. Endocrinol., February 1, 2007; 192(2): 361 - 369. [Abstract] [Full Text] [PDF]

				S. J. Lolait, L. Q. Stewart, D. S. Jessop, W. S. Young 3rd, and A.-M. O'Carroll The Hypothalamic-Pituitary-Adrenal Axis Response to Stress in Mice Lacking Functional Vasopressin V1b Receptors Endocrinology, February 1, 2007; 148(2): 849 - 856. [Abstract] [Full Text] [PDF]

				Q. Huang, E. Timofeeva, and D. Richard Corticotropin-releasing factor and its receptors in the brain of rats with insulin and corticosterone deficits. J. Mol. Endocrinol., October 1, 2006; 37(2): 213 - 226. [Abstract] [Full Text] [PDF]

				S. Yibchok-Anun, H. Cheng, P. A. Heine, and W. H. Hsu Characterization of receptors mediating AVP- and OT-induced glucagon release from the rat pancreas Am J Physiol Endocrinol Metab, July 1, 1999; 277(1): E56 - E62. [Abstract] [Full Text] [PDF]